Division of Infectious Diseases & Environmental Medicine
Leadership
Name:
John Zurlo, MD
Position:
Director, Division of Infectious Diseases
Email:
John.Zurlo@jefferson.edu
Contact
Name:
Division of Infectious Disease & Environmental Medicine
1101 Market Street
Suite 2720
Philadelphia, PA 19107
Contact Number(s):
- 215-955-7785
- 215-955-9362 (fax)
Research Activities
Publications
- Music Therapy Versus Cognitive Behavioral Therapy via Telehealth for Anxiety in Survivors of Cancer: A Randomized Clinical Trial
- Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration
- The right kind of rarefaction: Coronary microvascular remodeling in right ventricle failure
- Updating MISEV: When, What, How, and Why?
- Epinephrine and emergency medical services activation recommendations during acute allergic reactions in community settings: International consensus report
- Women with moderate anaemia prior to conception benefited most from nutrition interventions: a secondary analysis of the Women First preconception maternal nutrition trial
- An Introduction to Regression Discontinuity Design and Potential for Application in Neurology
- GLP-1s Versus DPP-4s and Risk of Dementia in Patients Requiring Hemodialysis: A Target Trial Emulation Study
- Tumor biology and access to care and metastatic breast cancer outcomes
- High body mass index at liver transplantation: A retrospective single-center analysis of blood product utilization and postoperative outcomes
- Infectious Disease Screening and Vaccinations Guidelines for Patients Initiating Immunosuppression for Dermatologic Conditions: A Multidisciplinary Design and Quality Improvement Initiative
- Cardiovascular risk in long-term survivors of breast, prostate, colon, and rectal cancer
- Personalized risk assessment of frailty in long-term cancer survivors
- Non-injectable versus injectable epinephrine treatment thresholds for acute allergic reactions in the community
- Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort
- Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study
- Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
- Income, Race-Ethnicity, and Dementia Risk Factors in the United States
- Dual-Level Pattern Tree for Visual Field Improves Glaucoma Progression and Polygenic Risk Prediction
- Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023